Ann: Life Science Update, page-53

what the ann said

sales growth
- exactly as stated in the quarterly about our deal with Ellume

covid-19
- "and AnteoTech remains on track to seek regulatory approval by the end of the quarter. ", nothing new there. from all previous communications from Anteo I think we can put " European" after seek.....

- "leveraging our manufacturing presence through Operon in Spain and expanding industry relationships in Europe, our initial market entry will be focused on select European countries. Discussions and engagement with potential distributors in Europe are also well underway."  

the only way I can interpret "expanding industry relationships" is we are working on more manufacturing in Europe. plus didn't Derek talk about manufacturing in the US and Asia.

discussions and engagement with potential distributors are also underway- all good

propective clinical trial
using both swab and saliva samples Novotech trial will start in Q2. just confirmed the starting date.

can't see anything  negative in it. we will see...